It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Histological and cytological observations of the human anterior cruciate ligament (ACL) had been described, but the differentiation potency based on their location is still unknown. To determine and compare proliferation and differentiation potential of cells derived from distal and middle thirds of the ACL remnant, ACL remnant was initially marked at the distal third (within 10 mm from the tibial insertion) and middle third (between 10–20 mm from the tibial insertion) and then dissected. Both the middle and distal third regions of ACL remnant were analyzed using CD34+ cell counting. Cell proliferation rate did not differ in both middle and distal third regions of ACL remnant, but they showed different characteristics in cell differentiation depending on their location. The distal third region of the ACL remnant had a tendency for chondrogenic differentiation with higher expression of CD34+ cells. On the other hand, the middle third region of ACL remnant had a strong tendency for osteogenic and ligamentous differentiation. Characteristics of the ACL remnant tissues should be considered when performing remnant-preserving or harvesting ACL remnants for tissue engineering.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 Department of Orthopaedic Surgery, Hanyang University Hospital, Seoul, Republic of Korea (GRID:grid.412147.5) (ISNI:0000 0004 0647 539X)
2 Hanyang University Institute for Rheumatology Research, Seoul, Republic of Korea (GRID:grid.49606.3d) (ISNI:0000 0001 1364 9317)
3 Hanyang University Institute for Rheumatology Research, Seoul, Republic of Korea (GRID:grid.49606.3d) (ISNI:0000 0001 1364 9317); Department of Bioenvironmental Technology, College of Natural Sciences, Seoul Women’s University, Seoul, Republic of Korea (GRID:grid.412487.c) (ISNI:0000 0004 0533 3082)
4 Department of Orthopaedic Surgery, Gangnam JS Hospital, Seoul, Republic of Korea (GRID:grid.412487.c)
5 Hanyang University Institute for Rheumatology Research, Seoul, Republic of Korea (GRID:grid.49606.3d) (ISNI:0000 0001 1364 9317); Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea (GRID:grid.412147.5) (ISNI:0000 0004 0647 539X)